16
Views
7
CrossRef citations to date
0
Altmetric
Original Articles

Comparative HPTLC Analysis of Antioxidant Compound Gallic Acid from in vitro and Naturally Grown Stevia rebaudiana

, &
Pages 397-405 | Received 15 Mar 2015, Accepted 24 Sep 2015, Published online: 02 Feb 2016
 

Abstract

Stevia rebaudiana Bertoni (Asteraceae) is a perennial shrub of South America, produces diterpene glycosides used as low calorie sweeteners. Stevioside and extracts prepared from the leaves have been used widely all over the world as sweetening agents, taste modifiers and sugar substitutes. Gallic acid (GA) is reported for its anti-inflammatory, anticancer, antiviral and antimelanogenic activities and many of these are mediated by its antioxidative capacity. Presently a study has been conducted on the comparative High Performance Thin Layer Chromatography (HPTLC) analysis of gallic acid from the dried leaf powder of in-situ and in-vitro grown S. rebaudiana. Nodal explants of S. rebaudiana were cultured in vitro in MS media supplemented with 6-benzyladenine (BA; 8.5 mM) and indole-3-butyric acid (IBA; 9.2 mM). The quantitative determination of gallic acid was performed on silica gel 60 F254 HPTLC plates as stationary phase. The linear ascending development was carried out in a twin trough glass chamber saturated with a mobile phase consisting of chloroform: ethyl acetate: formic acid (5:4:1) at room temperature (22±2°C). CAMAG TLC scanner-3 equipped with CATS software (version: 1.4.4.6337) was used for spectrodensitometric scanning and analysis in the ultraviolet region at λ=280 nm. The method was validated for linearity, precision and accuracy. Correlation coefficient, limit of detection (LOD), limit of quantification (LOQ) as well as recovery values were found to be satisfactory. S. rebaudiana raised in vitro (0.042 %) was found to contain higher amount of GA than their naturally growing counterparts (0.022 %).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.